Report #2835262

Received Apr 9, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex: Female
Age: Age unknown
State: TX
Recovered: Recovered
Vaccinated: —
Onset: —
Days to onset: —
Hospital days: —

Vaccines (1)

Type	Name	Manufacturer	Dose	Lot	Route / Site
COVID19	COVID19 (COVID19 (PFIZER-BIONTECH))	PFIZER\BIONTECH	1	—	—

Symptoms (1)

Herpes zoster reactivation

Symptom narrative

Shingles reactivation days after receiving the COVID-19 vaccine; This is a spontaneous report received from a Nurse from a sales representative. A female patient (not pregnant) received BNT162b2 omicron (kp.2) (COMIRNATY (2024-2025 FORMULA)), as dose 1, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: HERPES ZOSTER REACTIVATION (non-serious), outcome "recovered", described as "Shingles reactivation days after receiving the COVID-19 vaccine". It was unknown if therapeutic measures were taken as a result of herpes zoster reactivation. The information on the batch/lot number for BNT162b2 omicron (kp.2) will be requested and submitted if and when received.